“…The secondary noncutaneous forms are considered as epidermotropic metastasis originating from an underlying malignancy of the gastrointestinal tract (type 2), the urogenital tract (type 3), or an adenocarcinoma originating elsewhere. 4,5 Because of its rarity and unclear presentation features, EPDV is often diagnosed with delay, leading to the development of extensive lesions. Primary lesions follow an unpredictable course and, even though they are mostly slow-growing diseases with an indolent course, invasion can occur, and potential lymph node metastases or, rarely, hematogenous spread take place.…”